PYXS
NASDAQ
US
Pyxis Oncology, Inc. - Common Stock
$1.48
▲ +$0.01
(+0.68%)
Vol 196K
4
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$71.6M
ROE
-82.8%
D/E
0.06
Beta
1.37
52W
$1–$6
Wall Street Consensus
15 analysts · Apr 20267
Strong Buy
6
Buy
2
Hold
0
Sell
0
Strong Sell
86.7%
Buy Rating
Price Chart
Similar Stocks
ALDX
Aldeyra Therapeutics Inc
$99.9M
SPRB
Spruce Biosciences, Inc
$93.2M
COYA
Coya Therapeutics Inc
$121.4M
QTTB
Q32 Bio Inc
$40.9M
RCEL
AVITA Medical Inc
$105.2M
MCRB
Seres Therapeutics Inc
P/E 25.0
$134.6M
GOSS
Gossamer Bio Inc
$717.5M
HURA
TuHURA Biosciences Inc
$45.9M
ANIX
Anixa Biosciences Inc
$102.7M
ATYR
aTyr Pharma Inc
$76.7M
Earnings
Beat rate: 60.0%
Next Report
May 13, 2026
EPS Estimate: $-0.37
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.37 | — | — |
| Dec 2025 | $-0.34 | $-0.29 | +$0.05 |
| Sep 2025 | $-0.35 | $-0.35 | $0.00 |
| Jun 2025 | $-0.36 | $-0.30 | +$0.06 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -82.8% | -69.6% | -82.8% | -82.8% | -82.8% | -82.8% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -650.9% | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.07 | 0.08 | 0.07 | 0.07 | 0.06 | 0.06 |
| Current Ratio | 5.65 | 7.75 | 5.65 | 5.65 | 4.29 | 4.29 |
Key Ratios
ROA (TTM)
-63.0%
P/B
0.8
EPS (TTM)
$-1.57
CF/Share
$-2.48
52W High
$5.55
52W Low
$0.83
$0.83
52-Week Range
$5.55
How does PYXS compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
PYXS valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
0.8
▼
69%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
PYXS profitability vs Biotechnology peers
ROE
-82.8%
▼
23%
below
peers
(-67.3%)
vs Peers
vs Industry
Below avg
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-63.0%
▼
35%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
PYXS financial health vs Biotechnology peers
D/E ratio
0.1
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
In line
Current ratio
4.3
▼
3%
below
peers
(4.4)
vs Peers
vs Industry
In line
Beta
1.4
▲
41%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
PYXS fundamentals radar
PYXS
Peer median
Industry
PYXS profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
PYXS vs peers: key metrics
Latest News
No related news yet